iPSC is a specific type of cell therapy that uses induced pluripotent stem cells (iPSCs). It is based on the reprogramming of adult cells into a pluripotent state and subsequently differentiating them into specific cell types for therapeutic applications. In this approach, cells replicating the tissue affected by disease are created and used to test drug efficacy, side effects, and toxicity, as well as to develop new drugs and therapies.
Discover the different technology blocks for cell manufacturing – the cell sorter chip, micro-electrode array chip for electroporation, lens-free imaging chip, and multi-sensor chip for process analytical technology quality control. The integration of the different processes for iPSC manufacturing with chip technology allows for high-throughput systems with the potential for point-of-care applications – miniature bioreactors delivering the personalized therapy at the patient's bedside.